iInappropriate erythropoietin elaboration.
D000310:Adrenal Gland Neoplasms / Q000503:physiopathology*; D000818:Animals; D002277:Carcinoma / Q000503:physiopathology; D002528:Cerebellar Neoplasms / Q000503:physiopathology; D004921:Erythropoietin / Q000096:biosynthesis*; D005260:Female; D006394:Hemangiosarcoma / Q000503:physiopathology; D006801:Humans; D006977:Hypertension, Renal / Q000097:blood; D007668:Kidney / Q000187:drug effects; D007674:Kidney Diseases / Q000503:physiopathology*; D007680:Kidney Neoplasms / Q000503:physiopathology; D008113:Liver Neoplasms / Q000503:physiopathology; D009369:Neoplasms / Q000503:physiopathology*; D010673:Pheochromocytoma / Q000503:physiopathology; D011086:Polycythemia / Q000209:etiology*; D011139:Polythiazide / Q000494:pharmacology; D051381:Rats; D012083:Renin / Q000097:blood; D014594:Uterine Neoplasms / Q000503:physiopathology
D004921:Erythropoietin; D011139:Polythiazide; D012083:Renin